Drug intelligence / Profile preview

Yuleyin

Development stage
Preclinical
Administration
Oral
01

Overview

**Yuleyin** is an orally administered traditional Chinese medicine herbal formula used as one component of an integrated psychosomatic intervention for subthreshold depression. In a multicenter randomized controlled trial, the intervention combined Yuleyin with group psychotherapy and Jue tune music therapy; the complete intervention was associated with sustained within-group improvements in depressive-symptom scores and was reported as feasible with good safety. The individual botanical constituents, molecular targets, manufacturer, and a defined pharmacologic mechanism for Yuleyin were not reported in the identified public publication.

Other names
Yuleyin oral formula郁乐饮

Beyond the preview

Go deeper on Yuleyin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yuleyin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call